India Pharma Industry Seeks CDSCO Solvent Rules Clarity

Nov 11, 2026

Get tomorrow's supply chain signal

Daily supply-chain brief. Free, unsubscribe anytime.

The signal

India's pharmaceutical industry is seeking clarification from CDSCO (Central Drugs Standard Control Organisation) regarding new solvent regulations that have created supply chain uncertainty. The industry's request for clarity suggests the new rules may impact manufacturing operations, procurement practices, or inventory management in ways that are not yet fully understood by manufacturers.

#india-pharma

#cdsco-regulations

#solvent-rules

#supply-chain-compliance

#regulatory-clarity

#pharmaceutical-manufacturing

Go deeper:

Digital Twin in Supply Chain: What It Is and How to Choose Software

What a supply chain digital twin is, how to evaluate twin software, what it costs and how long it takes, and how it differs from network design tools.

Risk & DisruptionHigh Impact

Pharma Testing Under Siege: Geopolitical Chaos Threatens Drug Development

Oct 23, 2026

ProcurementHigh Impact

Pharma API Sourcing: How to Build Resilience Against Geopolitical Risk

Nov 3, 2026

ManufacturingHigh Impact

Pharmaceutical Manufacturers Face Critical Production Challenges

Aug 5, 2026

Get the daily supply chain briefing

Top stories, Pulse score, and disruption alerts. No spam. Unsubscribe anytime.

The signal

Related Articles